Beranda › Penyakit Crohn
Uji klinis Penyakit Crohn yang merekrut di AS
93 studi untuk Penyakit Crohn merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY35 studi
- Cleveland, OH19 studi
- St. Louis, MO19 studi
- Boston, MA19 studi
- Miami, FL19 studi
- Orlando, FL17 studi
- Houston, TX17 studi
- Atlanta, GA17 studi
- Tyler, TX16 studi
- San Diego, CA15 studi
- San Antonio, TX15 studi
- Los Angeles, CA15 studi
- Philadelphia, PA13 studi
- Colorado Springs, CO13 studi
- Durham, NC12 studi
- Providence, RI12 studi
- Tacoma, WA11 studi
- Pittsburgh, PA11 studi
- Seattle, WA11 studi
- Cincinnati, OH11 studi
- Baltimore, MD10 studi
- Washington, DC10 studi
- Indianapolis, IN10 studi
- Dallas, TX10 studi
- Lubbock, TX10 studi
- Tampa, FL10 studi
- Ann Arbor, MI9 studi
- Chicago, IL9 studi
- Louisville, KY9 studi
- Lewisville, TX9 studi
- Evanston, IL9 studi
- Rochester, MN8 studi
- Parma, OH8 studi
- Columbus, OH8 studi
- New Haven, CT8 studi
- Charlotte, NC8 studi
- Independence, MO8 studi
- Milwaukee, WI7 studi
- Lafayette, LA7 studi
- Queens, NY7 studi
Berdasarkan negara bagian
- Alabama9 studi
- Arizona17 studi
- Arkansas3 studi
- California37 studi
- Colorado18 studi
- Connecticut14 studi
- Distrik Columbia4 studi
- Florida27 studi
- Georgia22 studi
- Idaho4 studi
- Illinois18 studi
- Indiana13 studi
- Iowa8 studi
- Kansas11 studi
- Kentucky12 studi
- Louisiana11 studi
- Maryland15 studi
- Massachusetts27 studi
- Michigan20 studi
- Minnesota11 studi
- Mississippi3 studi
- Missouri21 studi
- Nevada8 studi
- New Hampshire3 studi
- New Jersey9 studi
- New York36 studi
- North Carolina20 studi
- Ohio30 studi
- Oklahoma8 studi
- Oregon4 studi
- Pennsylvania23 studi
- Rhode Island12 studi
- South Carolina11 studi
- South Dakota4 studi
- Tennessee10 studi
- Texas35 studi
- Utah8 studi
- Virginia15 studi
- Washington22 studi
- Wisconsin7 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Menerima pesertaStudi observasional
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07619547Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Menerima pesertaFase 3
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07697456Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07033208Investigating the Effect of the Non-nutritive Sweetener Sucralose in Inflammatory Bowel Disease
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07852273A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Menerima pesertaFase 4
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06581328Non-nutritive Sweeteners in Inflammatory Bowel Disease
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07769437A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05923073Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07196722A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Menerima pesertaFase 3
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06663332A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
Menerima peserta
Usia 16 hingga 75 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07671872Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 16 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06045754Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.